| 摘要 |
<p>The present invention relates to the field of differentiated stem cell production, particularly to the production of stem cell derived cardiomyocytes. The invention provides a method that uses follistatin as a biomarker to select for stem cells for stem cell differentiation in a simple streamlined process of cell production. The invention has particular application in the large scale production of populations of stem cell derived cardiomyocytes.</p> |
